Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Caenorhabditis elegans used to model weight gain resulting from antipsychotic use

Sep. 8, 2015

FORUM Pharmaceuticals describes PDE9A inhibitors that may improve cognition

Sep. 7, 2015

Cellsight Technologies PET tracer [18F]F-AraG first-in-human results are positive

Sep. 7, 2015

Dose-response effects described for encenicline in schizophrenia

Sep. 7, 2015

Amgen reports new BACE1 inhibitors for the treatment of AD

Sep. 4, 2015

Merck & Co. divulges A2A receptor antagonists

Sep. 4, 2015

Bristol-Myers Squibb discloses new gamma-secretase modulators for AD

Sep. 4, 2015

Janssen discloses new GPR120 agonists for diabetes

Sep. 4, 2015

Reduced dose of IL-37 attenuates arterial calcification

Sep. 3, 2015

GS-6615 shows short-term efficacy for the treatment of arrhythmia

Sep. 3, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...